Retrospective analysis of immune markers and BRAF status in melanoma patients: Implications for prognosis
Experimental Dermatology · 2024
DOI: 10.1111/exd.15105 ↗Kurz gefasst
Leserbrief in der Zeitschrift Experimental Dermatology, 2024. Verfasst von Nilesh Kodali und 6 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers New Jersey Medical School, Newark, New Jersey, USA. Hauptthemen laut MEDLINE: Melanoma, Proto-Oncogene Proteins B-raf, Skin Neoplasms. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rutgers New Jersey Medical School, Newark, New Jersey, USA.
- Rowan University Osteopathic School of Medicine, Stratford, New Jersey, USA.
- Department of Dermatology, Weill Cornell Medicine, New York, New York, USA.
ORCID-Profile: Nilesh Kodali
Zitieren
APA
Kodali, N., Alomary, S., Lin, M., Sikder, S., Bhattaru, A., Desai, S. D., & Lipner, S. R. (2024). Retrospective analysis of immune markers and BRAF status in melanoma patients: Implications for prognosis. Experimental Dermatology. https://doi.org/10.1111/exd.15105
Vancouver
Kodali N, Alomary S, Lin M, Sikder S, Bhattaru A, Desai SD, et al. Retrospective analysis of immune markers and BRAF status in melanoma patients: Implications for prognosis. Experimental Dermatology. 2024. doi:10.1111/exd.15105
BibTeX
@article{Kodali2024,
author = {Kodali, Nilesh and Alomary, Simona and Lin, Myriam and Sikder, Sonali and Bhattaru, Abhijit and Desai, Seema D and Lipner, Shari R},
title = {Retrospective analysis of immune markers and BRAF status in melanoma patients: Implications for prognosis},
journal = {Experimental Dermatology},
year = {2024},
doi = {10.1111/exd.15105}
}
EUVIMED